TY - JOUR
T1 - 3-month surgical outcomes of Implantable Collamer Lens implantation for myopic regression after laser vision correction surgeries
T2 - a retrospective case series
AU - Chung, Byunghoon
AU - Kim, Joon Hyun
AU - Kang, David S.Y.
AU - Kang, Dong Jun
AU - Kim, Eung Kweon
AU - Seo, Kyoung Yul
AU - Jun, Ikhyun
AU - Kim, Tae im
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Background: To investigate the surgical outcomes of implantable collamer lens (ICL) implantation in eyes with residual myopia after primary laser vision correction (LVC) surgeries. Methods: This study included patients who underwent ICL implantation and had a history of LVC surgery, including photorefractive keratectomy (PRK) or laser-assisted in situ keratomileusis (LASIK). Visual acuity and refractive error were assessed pre and 3-months postoperatively and the efficacy and safety indices calculated accordingly. Results: A total of 30 eyes of 17 patients were included in this study. At 3 months, the mean logMAR uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and spherical equivalent were − 0.03 ± 0.11 (include logMAR), − 0.04 ± 0.09 (include logMAR), and − 0.06 ± 0.33 diopters (D), respectively. The 3-month Snellen UDVA was better than 20/20 for 83% of eyes, and 97% of eyes showed an unchanged or improved CDVA after surgery. The mean efficacy and safety indices were 1.11 ± 0.22 and 1.13 ± 0.20, respectively. Further, 93 and 100% of eyes were within ±0.5 and ± 1.0 D of the attempted spherical equivalent refraction, respectively. Conclusions: ICL implantation in eyes with myopic regression after previous LVC surgery showed safe, effective, and predictable outcomes. Trial registration: retrospectively registered.
AB - Background: To investigate the surgical outcomes of implantable collamer lens (ICL) implantation in eyes with residual myopia after primary laser vision correction (LVC) surgeries. Methods: This study included patients who underwent ICL implantation and had a history of LVC surgery, including photorefractive keratectomy (PRK) or laser-assisted in situ keratomileusis (LASIK). Visual acuity and refractive error were assessed pre and 3-months postoperatively and the efficacy and safety indices calculated accordingly. Results: A total of 30 eyes of 17 patients were included in this study. At 3 months, the mean logMAR uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and spherical equivalent were − 0.03 ± 0.11 (include logMAR), − 0.04 ± 0.09 (include logMAR), and − 0.06 ± 0.33 diopters (D), respectively. The 3-month Snellen UDVA was better than 20/20 for 83% of eyes, and 97% of eyes showed an unchanged or improved CDVA after surgery. The mean efficacy and safety indices were 1.11 ± 0.22 and 1.13 ± 0.20, respectively. Further, 93 and 100% of eyes were within ±0.5 and ± 1.0 D of the attempted spherical equivalent refraction, respectively. Conclusions: ICL implantation in eyes with myopic regression after previous LVC surgery showed safe, effective, and predictable outcomes. Trial registration: retrospectively registered.
KW - Implantable collamer lens
KW - Laser-assisted in situ keratomileusis
KW - Myopic regression
KW - Photorefractive keratectomy
UR - http://www.scopus.com/inward/record.url?scp=85119148247&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119148247&partnerID=8YFLogxK
U2 - 10.1186/s12886-021-02163-3
DO - 10.1186/s12886-021-02163-3
M3 - Article
C2 - 34784925
AN - SCOPUS:85119148247
SN - 1471-2415
VL - 21
JO - BMC Ophthalmology
JF - BMC Ophthalmology
IS - 1
M1 - 397
ER -